Condition: Liver Steatosis · Fibrosis, Liver · Sponsor: Instituto Ecuatoriano de Enfermedades Digestivas
Currently, there is no description of the contribution of the endoscopic ultrasound (EUS)-guided shear wave elastography (SWE) when describing liver fibrosis in patients with screening criteria of metabolic dysfunction-associated steatotic liver disease (MASLD), with absent-to-mild liver fibrosis. Similar research has been published but using vibration-controlled transient elastography (VCTE), recommended mainly due to its lower cost and less invasiveness. However, VCTE is limited to the anatomical proportions of the patient's body, and cannot assess the right hepatic lobe with less reliability, contrary to the EUS-SWE.
This description comes directly from the study's public registry record.
Miguel Puga-Tejada, MD · +353 87 686 0537 · mpuga@ieced.ec
Jorge Baquerizo-Burgos, MD · +593 98 962 7111 · jorgebaquerizoburgos@gmail.com
Always discuss trial participation with your own doctor first.
| Instituto Ecuatoriano de Enfermedades Digestivas (IECED) Gastroclinica SA | Guayaquil, Guayas, Ecuador | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06102980